Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H BAILEY

Showing results (691-700 of 704) with videos related to

Pageof 71
Sort By:
Cell Reports|April 5, 2018
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome AtlasTheo A Knijnenburg, Linghua Wang, Michael T Zimmermann, et al.
The New England Journal of Medicine|March 8, 2023
Nirogacestat, a γ-Secretase Inhibitor for Desmoid TumorsMrinal Gounder, Ravin Ratan, Thierry Alcindor, et al.
Cell|April 15, 2025
Precision proteogenomics reveals pan-cancer impact of germline variantsFernanda Martins Rodrigues, Nadezhda V Terekhanova, Kathleen J Imbach, et al.
Cell|April 7, 2018
Comprehensive Characterization of Cancer Driver Genes and MutationsMatthew H Bailey, Collin Tokheim, Eduard Porta-Pardo, et al.
Cell|August 11, 2018
Comprehensive Characterization of Cancer Driver Genes and MutationsMatthew H Bailey, Collin Tokheim, Eduard Porta-Pardo, et al.
Nature Cancer|February 28, 2022
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncologyKatrin P Guillen, Maihi Fujita, Andrew J Butterfield, et al.
Cell|August 15, 2023
Pan-cancer proteogenomics connects oncogenic drivers to functional statesYize Li, Eduard Porta-Pardo, Collin Tokheim, et al.
Scientific Reports|July 4, 2025
Pan-cancer immune and stromal deconvolution predicts clinical outcomes and mutation profilesBhavneet Bhinder, Verena Friedl, Sunantha Sethuraman, et al.
Nature Communications|January 8, 2022
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatmentHua Sun, Song Cao, R Jay Mashl, et al.
Nature Communications|August 25, 2021
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatmentHua Sun, Song Cao, R Jay Mashl, et al.
Pageof 71

Showing results (691-700 of 704) with videos related to

Sort By:
Pageof 71
Cell Reports|April 5, 2018
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome AtlasTheo A Knijnenburg, Linghua Wang, Michael T Zimmermann, et al.
The New England Journal of Medicine|March 8, 2023
Nirogacestat, a γ-Secretase Inhibitor for Desmoid TumorsMrinal Gounder, Ravin Ratan, Thierry Alcindor, et al.
Cell|April 15, 2025
Precision proteogenomics reveals pan-cancer impact of germline variantsFernanda Martins Rodrigues, Nadezhda V Terekhanova, Kathleen J Imbach, et al.
Cell|April 7, 2018
Comprehensive Characterization of Cancer Driver Genes and MutationsMatthew H Bailey, Collin Tokheim, Eduard Porta-Pardo, et al.
Cell|August 11, 2018
Comprehensive Characterization of Cancer Driver Genes and MutationsMatthew H Bailey, Collin Tokheim, Eduard Porta-Pardo, et al.
Nature Cancer|February 28, 2022
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncologyKatrin P Guillen, Maihi Fujita, Andrew J Butterfield, et al.
Cell|August 15, 2023
Pan-cancer proteogenomics connects oncogenic drivers to functional statesYize Li, Eduard Porta-Pardo, Collin Tokheim, et al.
Scientific Reports|July 4, 2025
Pan-cancer immune and stromal deconvolution predicts clinical outcomes and mutation profilesBhavneet Bhinder, Verena Friedl, Sunantha Sethuraman, et al.
Nature Communications|January 8, 2022
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatmentHua Sun, Song Cao, R Jay Mashl, et al.
Nature Communications|August 25, 2021
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatmentHua Sun, Song Cao, R Jay Mashl, et al.
Pageof 71